ArticleInternational journal of clinical and experimental medicine2015

Baseline quantitative hepatitis B core antibody could strongly predict survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

Guosheng Yuan et al.PubMed ↗Full text ↗

No numbers read from the abstract.